Chemotherapy for a rare spinal cord tumor in children
Original title: Chemotherapy for Spinal Cord Intramedullary Pediatric Low-Grade Glioma-A Systematic Literature Review.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This looks back at children who were already treated, not a new trial.
The short version
Doctors looked back at 98 children with a rare spinal cord tumor who were given chemotherapy.
What was studied. Researchers reviewed 21 studies from 2000 to 2025. The studies covered 98 children with a rare, slow growing tumor inside the spinal cord who got chemotherapy.
What they found. The tumor went away fully in 9% of the children, and it shrank partly in another 9%. In 42% the tumor stayed the same size. The tumor grew in 26%, and 15% of the children died, most often because the tumor grew.
What this means, and what it doesn't
What it could mean: Chemotherapy may help hold these tumors steady when surgery cannot remove all of the tumor. In half of the cases it was the first treatment after surgery or a biopsy. In the other half it was used after the tumor came back or kept growing.
What it doesn't mean: This does not mean chemotherapy is proven to work for this tumor. It was not a new trial. The team only gathered reports of children already treated over many years. Nobody was compared to children who skipped chemotherapy. This tumor is rare, so the group was small. This is not a cure, and results were very different from child to child.
Source: PubMed, October 5, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.